Concepedia

Yi-Cheng Wang

YW

Statistics

Publications

15

Citations

789

H-Index

13

Active since

2011

Affiliations

Children's Oncology Group(Current)

University of Southern California

St. Jude Children's Research Hospital

Children's Mercy Hospital

Fred Hutch Cancer Center

Yi-Cheng Wang is an author at Children's Oncology Group specializing in medicine, natural sciences, and cell biology.

Top concepts

Publications per year

2011–2021

15

Publications

15

CD33 Splicing Polymorphism Determines Gemtuzumab Ozogamicin Response in De Novo Acute Myeloid Leukemia: Report From Randomized Phase III Children’s Oncology Group Trial AAML0531

Jatinder K. Lamba, Lata Chauhan, Miyoung Shin et al. · Journal of Clinical Oncology · 2017 · 146 citations · Full text

Improved outcomes for myeloid leukemia of Down syndrome: a report from the Children’s Oncology Group AAML0431 trial

Jeffrey W. Taub, Jason N. Berman, Johann Hitzler et al. · Blood · 2017 · 105 citations · Full text

Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia

Matthew A. Kutny, Todd A. Alonzo, Oussama Abla et al. · JAMA Oncology · 2021 · 91 citations · Full text

Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631

Matthew A. Kutny, Todd A. Alonzo, Robert B. Gerbing et al. · Journal of Clinical Oncology · 2017 · 88 citations · Full text

, , +15

High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children’s Oncology Group

George S. Laszlo, Todd A. Alonzo, Chelsea J. Gudgeon et al. · Journal of Hematology & Oncology · 2015 · 60 citations · Full text

1–5 of 15